Exabis Library
Welcome to the e-CCO Library!
P706: A distinct subset of tissue-resident Th17 cells expands in the inflamed intestines of Crohn’s Disease patients and responds to colitogenic bacteria
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P706: Caracterization of de novo inflammatory bowel disease (IBD) diagnosed in immigrants migrating from low to high prevalence areas of IBD: a case-control study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P706: Lower need for adalimumab dose intensification in IBD patients treated with combined immune suppression compared with adalimumab monotherapy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P706: Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P706: Patient knowledge towards biological treatment in inflammatory bowel diseases: a cross-sectional survey
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P707 Anti-TNFα therapy has no effect on bone mineral density in younger patients with inflammatory bowel disease: A single-centre observational study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P707: 38 Weeks treatment of UC patients with different daily doses of mesalazine
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P707: Increasing abundance of faecalibacterium prausnitzii is associated with decreased intestinal inflammation in Crohn’s disease: A longitudinal study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P707: Microbial signature of the colon is not associated with response to vedolizumab in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P707: Paediatric IBD patients do not meet the daily recommendations of vitamin D and calcium intake: survey based analysis in a tertiary centre
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P707: Using urgent small bowel ultrasound (SBUS) as a tool for decision-making in patients with inflammatory bowel disease (IBD): retrospective analysis of United Kingdom (UK) patients' outcome.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P708 The effect of psychotherapy on quality of life in inflammatory bowel disease patients: A systematic literature review
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P708: Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P708: Home-based infusion therapy for biologic agent administration as a therapeutic option for patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P708: Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P708: Post-COVID-19 and Quality of Life in Patients with Immune Mediated Inflammatory Diseases
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P709 Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P709: Distinct Pattern of Gut Microbial Dysbiosis in Crohn's Disease and Intestinal Tuberculosis - A Machine Learning-based classification model
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM